{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T09:11:28Z","timestamp":1790845888430,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.ejmech.2019.111598","type":"journal-article","created":{"date-parts":[[2019,8,6]],"date-time":"2019-08-06T19:41:53Z","timestamp":1565120513000},"page":"111598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Discovery of \u03b4-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies"],"prefix":"10.1016","volume":"181","author":[{"given":"Yingying","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziwen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamed","family":"Alsulami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6609-0083","authenticated-orcid":false,"given":"Hua-Li","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2798-6557","authenticated-orcid":false,"given":"Wenjian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2019.111598_bib1","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1056\/NEJMra0909142","article-title":"Alzheimer's disease","volume":"362","author":"Querfurth","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ejmech.2019.111598_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jalz.2018.02.001","article-title":"Alzheimer's disease facts and figures","volume":"14","author":"Alzheimer's","year":"2018","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.ejmech.2019.111598_bib3","doi-asserted-by":"crossref","first-page":"a006262","DOI":"10.1101\/cshperspect.a006262","article-title":"Biochemistry of amyloid \u03b2-protein and amyloid deposits in Alzheimer disease","volume":"2","author":"Masters","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"issue":"10043","key":"10.1016\/j.ejmech.2019.111598_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0140-6736(15)01124-1","article-title":"Alzheimer's disease","volume":"388","author":"Scheltens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2019.111598_bib5","doi-asserted-by":"crossref","first-page":"6765","DOI":"10.1039\/C3CS60460H","article-title":"BACE1 (beta-secretase) inhibitors for the treatment of Alzheimer's disease","volume":"43","author":"Ghosh","year":"2014","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.ejmech.2019.111598_bib6","doi-asserted-by":"crossref","first-page":"12174","DOI":"10.1073\/pnas.94.22.12174","article-title":"Response-reinforcement learning is dependent on N-methyl-D-aspartate receptor activation in the nucleus accumbens core","volume":"94","author":"Kelley","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"7","key":"10.1016\/j.ejmech.2019.111598_bib7","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1021\/jm400970m","article-title":"Oxidative stress in Alzheimer's disease: are we connecting the dots?","volume":"57","author":"Rosini","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib8","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2016.04.013","article-title":"Recent progress in multifunctional metal chelators as potential drugs for Alzheimer's disease","volume":"327","author":"Santos","year":"2016","journal-title":"Coord. Chem. Rev."},{"issue":"7\u20138","key":"10.1016\/j.ejmech.2019.111598_bib9","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s007020200089","article-title":"Inhibition of acetyl- and butyryl-cholinesterase in the cerebrospinal fluid of patients with Alzheimer's disease by rivastigmine: correlation with cognitive benefit","volume":"109","author":"Giacobini","year":"2002","journal-title":"J.\u00a0Neural Transm."},{"key":"10.1016\/j.ejmech.2019.111598_bib10","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2174\/1871527313666141023141545","article-title":"Status of acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease and type 2 diabetes mellitus","volume":"13","author":"Mushtaq","year":"2014","journal-title":"CNS Neurol. Disord. - Drug Targets"},{"issue":"1","key":"10.1016\/j.ejmech.2019.111598_bib11","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1080\/14756366.2017.1406485","article-title":"New cyclopentaquinoline hybrids with multifunctional capacities for the treatment of Alzheimer's disease","volume":"33","author":"Czarnecka","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2019.111598_bib12","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1038\/aps.2016.87","article-title":"DL0410, a novel dual cholinesterase inhibitor, protects mouse brains against A beta-induced neuronal damage via the Akt\/JNK signaling pathway","volume":"37","author":"Zhou","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2019.111598_bib13","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.ejmech.2016.12.003","article-title":"Novel ferulic amide derivatives with tertiary amine side chain as acetylcholinesterase and butyrylcholinesterase inhibitors: the influence of carbon spacer length, alkylamine and aromatic group","volume":"126","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib14","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.bioorg.2018.08.009","article-title":"Highly functionalized 2-amino-4H-pyrans as potent cholinesterase inhibitors","volume":"81","author":"Kumar","year":"2018","journal-title":"Bioorg. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2019.111598_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1476-5381.1993.tb13486.x","article-title":"Degradation of acetylcholine in human airways: role of butyrylcholinesterase","volume":"108","author":"Norel","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2019.111598_bib16","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2009.12.044","article-title":"The history of the cholinergic hypothesis","volume":"221","author":"Contestabile","year":"2011","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111598_bib17","doi-asserted-by":"crossref","first-page":"17213","DOI":"10.1073\/pnas.0508575102","article-title":"Selective butyrylcholinesterase inhibition elevates brain acetylcholine, augments learning and lowers Alzheimer beta-amyloid peptide in rodent","volume":"102","author":"Greig","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2019.111598_bib18","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2147\/CIA.S129145","article-title":"Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson's disease dementia","volume":"12","author":"Kandiah","year":"2017","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.ejmech.2019.111598_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.neuroscience.2015.04.039","article-title":"Butyrylcholinesterase-knockout reduces brain deposition of fibrillar \u03b2-amyloid in an Alzheimer mouse model","volume":"298","author":"Reid","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmech.2019.111598_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbr.2015.08.026","article-title":"Learning performances and vulnerability to amyloid toxicity in the butyrylcholinesterase knockout mouse","volume":"296","author":"Maurice","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2019.111598_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.cbi.2016.04.022","article-title":"Reduced fibrillar beta-amyloid in subcortical structures in a butyrylcholinesterase-knockout Alzheimer disease mouse model","volume":"259","author":"Darvesh","year":"2016","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejmech.2019.111598_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainres.2017.07.009","article-title":"Butyrylcholinesterase-knockout reduces fibrillar beta-amyloid and conserves (18)FDG retention in 5XFAD mouse model of Alzheimer's disease","volume":"1671","author":"DeBay","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2019.111598_bib23","doi-asserted-by":"crossref","first-page":"14642","DOI":"10.1021\/bi971425+","article-title":"Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase","volume":"36","author":"Saxena","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2019.111598_bib24","doi-asserted-by":"crossref","first-page":"41141","DOI":"10.1074\/jbc.M210241200","article-title":"Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products","volume":"278","author":"Nicolet","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib25","doi-asserted-by":"crossref","first-page":"8167","DOI":"10.1021\/jm501195e","article-title":"Discovery, biological evaluation, and crystal structure of a novel nanomolar selective butyrylcholinesterase inhibitor","volume":"57","author":"Brus","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.bioorg.2018.01.030","article-title":"Alkynyl and beta-ketophosphonates: selective and potent butyrylcholinesterase inhibitors","volume":"77","author":"Cavallaro","year":"2018","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejmech.2018.02.002","article-title":"Tricyclic pyrazolo[1,5-d][1,4] benzoxazepin-5(6H)-one scaffold derivatives: synthesis and biological evaluation as selective BuChE inhibitors","volume":"147","author":"Chen","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.ejmech.2018.01.007","article-title":"Chameleon-like behavior of indolylpiperidines in complex with cholinesterases targets: potent butyrylcholinesterase inhibitors","volume":"145","author":"Chierrito","year":"2018","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2019.111598_bib29","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1021\/acschemneuro.7b00461","article-title":"Design, synthesis, and biological evaluation of 1-Benzylamino-2-hydroxyalkyl derivatives as new potential disease-modifying multifunctional anti-Alzheimer's agents","volume":"9","author":"Panek","year":"2018","journal-title":"ACS Chem. Neurosci."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111598_bib30","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1021\/acs.jmedchem.7b01086","article-title":"The magic of crystal structure-based inhibitor optimization: development of a butyrylcholinesterase inhibitor with picomolar affinity and in\u00a0vivo activity","volume":"61","author":"Kosak","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib31","doi-asserted-by":"crossref","first-page":"5339","DOI":"10.1021\/cr2003294","article-title":"Recent developments in the synthesis and application of sultones","volume":"112","author":"Mondal","year":"2012","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2019.111598_bib32","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1021\/jm8014662","article-title":"4-Benzyloxy-gamma-Sultone derivatives: discovery of a novel family of non-nucleoside inhibitors of human cytomegalovirus and varicella zoster virus","volume":"52","author":"De Castro","year":"2009","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib33","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.bmcl.2014.03.012","article-title":"Synthesis and anti-BVDV activity of novel delta-sultones in\u00a0vitro: implications for HCV therapies","volume":"24","author":"Xu","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2019.111598_bib34","doi-asserted-by":"crossref","first-page":"9430","DOI":"10.1002\/anie.201309399","article-title":"Sulfur(VI) fluoride exchange (SuFEx): another good reaction for click chemistry","volume":"53","author":"Dong","year":"2014","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111598_bib35","doi-asserted-by":"crossref","first-page":"14155","DOI":"10.1002\/anie.201608807","article-title":"A\u00a0heck-matsuda process for the synthesis of -arylethenesulfonyl fluorides: selectively addressable bis-electrophiles for SuFEx click chemistry","volume":"55","author":"Qin","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2019.111598_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/nchem.2796","article-title":"Bifluoride-catalysed sulfur(VI) fluoride exchange reaction for the synthesis of polysulfates and polysulfonates","volume":"9","author":"Gao","year":"2017","journal-title":"Nat. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib37","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1002\/adsc.201700887","article-title":"Synthesis of a class of fused delta-sultone heterocycles via DBU-catalyzed direct annulative SuFEx click of ethenesulfonyl fluorides and pyrazolones or 1,3-dicarbonyl compounds","volume":"359","author":"Chen","year":"2017","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2019.111598_bib38","doi-asserted-by":"crossref","first-page":"9011","DOI":"10.1039\/C8CC04032J","article-title":"A\u00a0portal to a class of novel sultone-functionalized pyridines via an annulative SuFEx process employing earth abundant nickel catalysts","volume":"54","author":"Chen","year":"2018","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2019.111598_bib39","first-page":"30333","article-title":"Contemporary medicinal-chemistry strategies for the discovery of selective butyrylcholinesterase inhibitors","volume":"S1359\u20136446","author":"Jing","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2019.111598_bib40","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.ejmech.2018.09.031","article-title":"Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease","volume":"158","author":"Li","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib41","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.ejmech.2016.07.043","article-title":"Synthesis and structure-activity relationship study of tacrine-based pyrano[2,3-c]pyrazoles targeting AChE\/BuChE and 15-LOX","volume":"123","author":"Pourabdi","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib42","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.ejmech.2017.07.072","article-title":"New racemic annulated pyrazolo[1,2-b]phthalazines as tacrine-like AChE inhibitors with potential use in Alzheimer's disease","volume":"139","author":"Jalili-Baleh","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2019.111598_bib43","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1080\/14756366.2018.1488696","article-title":"Design, synthesis and biological evaluation of tricyclic pyrazolo[1,5-c][1,3] benzoxazin-5(5H)-one scaffolds as selective BuChE inhibitors","volume":"33","author":"Qiu","year":"2018","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"issue":"16","key":"10.1016\/j.ejmech.2019.111598_bib44","doi-asserted-by":"crossref","first-page":"7683","DOI":"10.1021\/acs.jmedchem.6b00356","article-title":"Discovery and structure-activity relationships of a highly selective butyrylcholinesterase inhibitor by structure-based virtual screening","volume":"59","author":"Dighe","year":"2016","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib45","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2015.03.039","article-title":"Design and synthesis of celastrol derivatives as anticancer agents","volume":"95","author":"Tang","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib46","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.biopha.2016.02.020","article-title":"Identification of novel FAK and S6K1 dual inhibitors from natural compounds via ADMET screening and molecular docking","volume":"80","author":"Thiyagarajan","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejmech.2019.111598_bib47","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ejoc.201601093","article-title":"Synthesis of tetrasubstituted pyrazoles from substituted hydrazines and \u03b2-keto esters","volume":"2016","author":"Bakanas","year":"2016","journal-title":"Eur. J. Org. Chem."},{"key":"10.1016\/j.ejmech.2019.111598_bib48","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1016\/j.bmc.2018.03.006","article-title":"Structure-activity relationships in a new class of non-substrate-like covalent inhibitors of the bacterial glycosyltransferase LgtC","volume":"26","author":"Xu","year":"2018","journal-title":"Bioorg. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523419307329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:05:39Z","timestamp":1759327539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523419307329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":48,"alternative-id":["S0223523419307329"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111598","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of \u03b4-sultone-fused pyrazoles for treating Alzheimer's disease: Design, synthesis, biological evaluation and SAR studies","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2019.111598","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"111598"}}